Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Pulmonary Medicine|December 23, 2011
The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary DiseasesKazuhiro Usui, Tomonori Ushijima, Yoshiaki Tanaka, et al.Journal of Medical Case Reports|February 22, 2014
Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case reportSayaka Ohara, Tomonori Ushijima, Mariko Gunji, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Clinical analysis of 12 cases of pneumothorax during intensive chemotherapy for malignant neoplasms]Noriko Yamada, Norifumi Abe, Kazuhiro Usui, et al.Thoracic Cancer|August 17, 2023
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101Yosuke Kawashima, Osamu Ishimoto, Eisaku Miyauchi, et al.BMJ Open|January 5, 2022
Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational studyKageaki Watanabe, Kiyotaka Yoh, Yukio Hosomi, et al.Japanese Journal of Clinical Oncology|October 27, 2022
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancerYasushi Goto, Kiyotaka Yoh, Terufumi Kato, et al.Japanese Journal of Clinical Oncology|December 14, 2024
Outcome of osimertinib-treated patients with epidermal growth factor receptor mutation-positive nonsmall cell lung cancer requiring dose reduction: a secondary analysis of the Reiwa studyNobuyasu Awano, Kiyotaka Yoh, Kazuhiro Usui, et al.Case Reports in Oncology|February 23, 2023
Primary Pleural Angiosarcoma Treated with Nivolumab and Ipilimumab: A Case ReportMikako Nakamura, Kaoru Watanabe, Taku Nishimura, et al.Lung Cancer (Amsterdam, Netherlands)|February 18, 2006
A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancerAkira Inoue, Kazuhiro Usui, Osamu Ishimoto, et al.Journal of Thoracic Disease|May 20, 2021
Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trialShugo Uematsu, Atsushi Sano, Kazutoshi Isobe, et al.Pageof 7